Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 2	2026-02-09		NCT06052839

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dan Zandberg	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
UPMC Hillman Cancer Center	Pittsburgh	United States	330

Clinical trials